RITZ-5: randomized intravenousTeZosentan (an endothelin-A/B antagonist)for the treatment of pulmonary edema-Reference-Cited by-同舟云学术

RITZ-5: randomized intravenousTeZosentan (an endothelin-A/B antagonist)for the treatment of pulmonary edema

Published:2003-01 Issue:2 Volume:41 Page:204-210
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Kaluski Edo,Kobrin Isaac,Zimlichman Reuven,Marmor Alon,Krakov Oscar,Milo Olga,Frey Aline,Kaplan Shoshana,Krakover Rikardo,Caspi Avi,Vered Zvi,Cotter Gad

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference19 articles.

1. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema;Cotter;Lancet,1998

2. High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema;Sharon;J Am Coll Cardiol,2000

3. Acute heart failure;Cotter;Eur J Heart Failure,2002

4. The role of cardiac power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute congestive heart failure;Cotter;Eur Heart J,2002

5. A novel potent vasoconstrictor peptide produced by vascular endothelial cells;Yanagisawa;Nature,1988

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vasodilators for Acute Heart Failure — A Systematic Review with Meta-Analysis;NEJM Evidence;2024-05-28

2. Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension: Focus on Phosphodiesterase Inhibitors;Pharmaceuticals;2022-08-19

3. Endothelin-1 axes in the framework of predictive, preventive and personalised (3P) medicine;EPMA Journal;2021-08-04

4. Endothelin: 30 Years From Discovery to Therapy;Hypertension;2019-12

5. Endothelins in cardiovascular biology and therapeutics;Nature Reviews Cardiology;2019-03-13